TBIO

Translate Bio Stock Price

27.50
-8.11 (-22.77%)
Upgrade to Real-Time
Afterhours (Closed)
27.50

Low
11.91

52 Week Range

High
36.98

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Translate Bio Inc TBIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-8.11 -22.77% 27.50 20:00:00
Open Price Low Price High Price Close Price Prev Close
33.4033 27.37 34.00 27.64 35.61
Bid Price Ask Price Spread News
27.33 28.30 0.97 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
23,706 2,629,883 $ 29.16 $ 76,683,883 - 11.91 - 36.98
Last Trade Time Type Quantity Stock Price Currency
19:59:13 10 $ 27.87 USD

Period:

Draw Mode:

Translate Bio Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 2.07B 75.23M 53.26M $ 138.81M $ 21.22M -0.88 -120.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 301.80k 1.40%

more financials information »

Translate Bio News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical TBIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week30.7836.9827.3734.011,041,758-3.28-10.66%
1 Month28.585736.9827.0930.83887,449-1.09-3.8%
3 Months19.1836.9815.8424.06878,1388.3243.38%
6 Months24.1036.9815.439822.361,069,5013.4014.11%
1 Year15.6036.9811.9120.111,088,18611.9076.28%
3 Years14.5036.984.8117.86654,46513.0089.66%
5 Years0.36536.980.15112.52792,08527.147,434.25%

Translate Bio Description

Translate Bio Inc is a clinical-stage mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. The company is developing MRT5005, for the treatment of cystic fibrosis (CF) and MRT5201, for the treatment of ornithine transcarbamylase (OTC) deficiency.


Your Recent History
NASDAQ
TBIO
Translate ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.